United States · FDA National Drug Code directory
Liomny
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 42794-133_441e1bcc-ba19-6122-e063-6294a90a7e80
- Product NDC
- 42794-133
- Form
- TABLET
- Composition / generic term
- Liothyronine Sodium
- Labeler
- SIGMAPHARM LABORATORIES, LLC
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20251121
- Source listing expiry
- 20261231
Source-listed ingredients
- LIOTHYRONINE SODIUM — 50 ug/1
These values do not establish equivalence or a dose recommendation.
Packages
- 100 TABLET in 1 BOTTLE (42794-133-02) · 42794-133-02
- 1000 TABLET in 1 BOTTLE (42794-133-06) · 42794-133-06
- 30 TABLET in 1 BOTTLE (42794-133-08) · 42794-133-08
- 60 TABLET in 1 BOTTLE (42794-133-10) · 42794-133-10
- 90 TABLET in 1 BOTTLE (42794-133-12) · 42794-133-12
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →